Integrative understanding of immune-metabolic interaction

키워드

참고문헌 (91)

1. Medzhitov R, "Origin and physiological roles of inflammation", Nature, 454, pp.428~435 (2008)
2. Medzhitov R, "The spectrum of inflammatory responses", Science, 374, pp.1070~1075 (2021)
3. 노종성, "Damage-Associated Molecular Patterns in Inflammatory Diseases", Immune Network, 18(4), pp.1~14 (2018), 대한면역학회[DOI]
4. Harding SM, "Mitotic progression following DNA damage enables pattern recognition within micronuclei", Nature, 548, pp.466~470 (2017)
5. Urano F, "Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1", Science, 287, pp.664~666 (2000)
6. Keestra-Gounder AM, "NOD1 and NOD2 signalling links ER stress with inflammation", Nature, 532, pp.394~397 (2016)
7. Duewell P, "NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals", Nature, 464, pp.1357~1361 (2010)
8. Hornung V, "Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization", Nat Immunol, 9, pp.847~856 (2008)
9. Yabal M, "Stressing out the mitochondria : mechanistic insights into NLRP3 inflammasome activation", J Leukoc Biol, 105, pp.377~399 (2019)
10. Kotas ME, "Homeostasis, inflammation, and disease susceptibility", Cell, 160, pp.816~827 (2015)
11. Chovatiya R, "Stress, inflammation, and defense of homeostasis", Mol Cell, 54, pp.281~288 (2014)
12. Liu L, "Proinflammatory signal suppresses proliferation and shifts macrophage metabolism from Myc-dependent to HIF1α-dependent", Proc Natl Acad Sci U S A, 113, pp.1564~1569 (2016)
13. Van den Bossche J, "Metabolic characterization of polarized M1 and M2 bone marrow-derived macrophages using real-time extracellular flux analysis", J Vis Exp, 105, pp.53424~ (2015)
14. Burke JD, "Beta interferon regulation of glucose metabolism is PI3K", Akt dependent and important for antiviral activity against coxsackievirus B3, 2014, pp.88, 3485~3495
15. Dror E, "Postprandial macrophage-derived IL-1β stimulates insulin, and both synergistically promote glucose disposal and inflammation", Nat Immunol, 18, pp.283~292 (2017)
16. Jessop F, "Interferon gamma reprograms host mitochondrial metabolism through inhibition of complex II to control intracellular bacterial replication", Infect Immun, 88, pp.e00744-19~ (2020)
17. Tan Z, "Pyruvate dehydrogenase kinase 1 participates in macrophage polarization via regulating glucose metabolism", J Immunol, 194, pp.6082~6089 (2015)
18. Vats D, "Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation", Cell Metab, 4, pp.13~24 (2006)
19. Michelucci A, "Immuneresponsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production", Proc Natl Acad Sci U S A, 110, pp.7820~7825 (2013)
20. Lampropoulou V, "Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation", Cell Metab, 24, pp.158~166 (2016)
21. Jha AK, "Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization", Immunity, 42, pp.419~430 (2015)
22. Tannahill GM, "Succinate is an inflammatory signal that induces IL-1β through HIF-1α", Nature, 496, pp.238~242 (2013)
23. Meiser J, "Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression", J Biol Chem, 291, pp.3932~3946 (2016)
24. Mills EL, "Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1", Nature, 556, pp.113~117 (2018)
25. Bambouskova M, "Electrophilic properties of itaconate and derivatives regulate the IκBξ-ATF3 inflammatory axis", Nature, 556, pp.501~504 (2018)
26. Ecker J, "Induction of fatty acid synthesis is a key requirement for phagocytic differentiation of human monocytes", Proc Natl Acad Sci U S A, 107, pp.7817~7822 (2010)
27. Chapman NM, "Hallmarks of T-cell exit from quiescence", Cancer Immunol Res, 6, pp.502~508 (2018)
28. Rathmell JC, "IL-7 enhances the survival and maintains the size of naive T cells", J Immunol, 167, pp.6869~6876 (2001)
29. Zhang S, "Newly generated CD4(+)T cells acquire metabolic quiescence after thymic egress", J Immunol, 200, pp.1064~1077 (2018)
30. Miller ML, "Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells", Proc Natl Acad Sci U S A, 111, pp.7397~7402 (2014)
31. Fox CJ, "Fuel feeds function : energy metabolism and the T-cell response", Nat Rev Immunol, 5, pp.844~852 (2005)
32. Loftus RM, "Immunometabolism : cellular metabolism turns immune regulator", J Biol Chem, 291, pp.1~10 (2016)
33. Glick GD, "Anaplerotic metabolism of alloreactive T cells provides a metabolic approach to treat graft-versus-host disease", J Pharmacol Exp Ther, 351, pp.298~307 (2014)
34. Pearce EL, "Metabolic pathways in immune cell activation and quiescence", Immunity, 38, pp.633~643 (2013)
35. Wang R, "The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation", Immunity, 35, pp.871~882 (2011)
36. Sinclair LV, "Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation", Nat Immunol, 14, pp.500~508 (2013)
37. Lochner M, "Fatty acid metabolism in the regulation of T cell function", Trends Immunol, 36, pp.81~91 (2015)
38. Swamy M, "Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy", Nat Immunol, 17, pp.712~720 (2016)
39. Lunt SY, "Aerobic glycolysis : meeting the metabolic requirements of cell proliferation", Annu Rev Cell Dev Biol, 27, pp.441~464 (2011)
40. Chang CH, "Posttranscriptional control of T cell effector function by aerobic glycolysis", Cell, 153, pp.1239~1251 (2013)
41. Nagy E, "Identification of the NAD(+)-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain", Biochem Biophys Res Commun, 275, pp.253~260 (2000)
42. Boukouris AE, "Metabolic enzymes moonlighting in the nucleus : metabolic regulation of gene transcription", Trends Biochem Sci, 41, pp.712~730 (2016)
43. Chi H, "Regulation and function of mTOR signalling in T cell fate decisions", Nat Rev Immunol, 12, pp.325~338 (2012)
44. Su X, "Interferon-γ regulates cellular metabolism and mRNA translation to potentiate macrophage activation", Nat Immunol, 16, pp.838~849 (2015)
45. Feingold KR, "Mechanisms of triglyceride accumulation in activated macrophages", J Leukoc Biol, 92, pp.829~839 (2012)
46. Rodríguez-Prados JC, "Substrate fate in activated macrophages : a comparison between innate, classic, and alternative activation", J Immunol, 185, pp.605~614 (2010)
47. Huang SC, "Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation", Immunity, 45, pp.817~830 (2016)
48. Wu D, "Type 1 interferons induce changes in core metabolism that are critical for immune function", Immunity, 44, pp.1325~1336 (2016)
49. York AG, "Limiting cholesterol biosynthetic flux spontaneously engages type I IFN signaling", Cell, 163, pp.1716~1729 (2015)
50. Fultang L, "macrophage-derived IL1β and TNFα regulate arginine metabolism in neuroblastoma", Cancer Res, 79, pp.611~624 (2019)
51. Jager J, "Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression", Endocrinology, 148, pp.241~251 (2007)
52. Lagathu C, "Longterm treatment with interleukin-1beta induces insulin resistance in murine and human adipocytes", Diabetologia, 49, pp.2162~2173 (2006)
53. Gao D, "Interleukin-1βmediates macrophage-induced impairment of insulin signaling in human primary adipocytes", Am J Physiol Endocrinol Metab, 307, pp.E289~ (2014)
54. Senn JJ, "Interleukin-6 induces cellular insulin resistance in hepatocytes", Diabetes, 51, pp.3391~3399 (2002)
55. Kim H-J, "Differential effects of interleukin-6 and-10 on skeletal muscle and liver insulin action in vivo", Diabetes, 53, pp.1060~1067 (2004)
56. Cai D, "Local and systemic insulin resistance resulting from hepatic activation of IKK-βand NF-κB", Nat Med, 11, pp.183~190 (2005)
57. Hotamisligil GS, "Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance", J Clin Invest, 95, pp.2409~2415 (1995)
58. Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha : direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
59. Uysal KT, "Protection from obesity-induced insulin resistance in mice lacking TNF-α function", Nature, 389, pp.610~614 (1997)
60. Wieser V, "Adipose type I interferon signalling protects against metabolic dysfunction", Gut, 67, pp.157~165 (2018)
61. Bruce CR, "Cytokine regulation of skeletal muscle fatty acid metabolism : effect of interleukin-6 and tumor necrosis factor-alpha", Am J Physiol Endocrinol Metab, 287, pp.E616~ (2004)
62. Bouhlel MA, "PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties", Cell Metab, 6, pp.137~143 (2007)
63. Nobs SP, "PPARγ in dendritic cells and T cells drives pathogenic type-2 effector responses in lung inflammation", J Exp Med, 214, pp.3015~3035 (2017)
64. Kang K, "Adipocytederived Th2 cytokines and myeloid PPARδ regulate macrophage polarization and insulin sensitivity", Cell Metab, 7, pp.485~495 (2008)
65. Odegaard JI, "Alternative M2 activation of kupffer cells by PPARδAmeliorates obesity-induced insulin resistance", Cell Metab, 7, pp.496~507 (2008)
66. Colegio OR, "Functional polarization of tumour-associated macrophages by tumourderived lactic acid", Nature, 513, pp.559~563 (2014)
67. Zhang J, "Endothelial lactate controls muscle regeneration from ischemia by inducing M2-like macrophage polarization", Cell Metab, 31, pp.1136~1153 (2020)
68. Haniuda K, "Metabolic reprogramming induces germinal center B cell differentiation through Bcl6 locus remodeling", Cell Rep, 33, pp.108333~ (2020)
69. Weisel FJ, "Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis", Nat Immunol, 21, pp.331~342 (2020)
70. Ricardo-Gonzalez RR, "IL-4", STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity, 2010, pp.107, 22617~22622
71. Tsao CH, "Interleukin-4 regulates lipid metabolism by inhibiting adipogenesis and promoting lipolysis", J Lipid Res, 55, pp.385~397 (2014)
72. Lee MW, "Activated type 2 innate lymphoid cells regulate beige fat biogenesis", Cell, 160, pp.74~87 (2015)
73. BrestoffJR, "Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity", Nature, 519, pp.242~246 (2015)
74. Knudsen NH, "Interleukin-13 drives metabolic conditioning of muscle to endurance exercise", Science, 368, pp.eaat3987~ (2020)
75. Gagliani N, "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation", Nature, 523, pp.221~225 (2015)
76. Schenk U, "ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors", Sci Signal, 4, pp.ra12~ (2011)
77. Gerriets VA, "Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation", J Clin Invest, 125, pp.194~207 (2015)
78. Michalek RD, "Cutting edge : distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets", J Immunol, 186, pp.3299~3303 (2011)
79. Shi LZ, "HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells", J Exp Med, 208, pp.1367~1376 (2011)
80. Berod L, "De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells", Nat Med, 20, pp.1327~1333 (2014)
81. Xu T, "Metabolic control of T(H)17 and induced T(reg)cell balance by an epigenetic mechanism", Nature, 548, pp.228~233 (2017)
82. Shi W, "Anti-IL-17 antibody improves hepatic steatosis by suppressing interleukin-17-related fatty acid synthesis and metabolism", Clin Dev Immunol, 2013, pp.253046~ (2013)
83. Zúñiga LA, "IL-17regulates adipogenesis, glucose homeostasis, and obesity", J Immunol, 185, pp.6947~6959 (2010)
84. Ahmed M, "IL-17 inhibits adipogenesis in part via C", EBPα, PPARγ and Krüppel-like factors, 2013, pp.61, 898~905
85. Kohlgruber AC, "γδT cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis", Nat Immunol, 19, pp.464~474 (2018)
86. Hu B, "γδ T cells and adipocyte IL-17RC control fat innervation and thermogenesis", Nature, 578, pp.610~614 (2020)
87. Feuerer M, "Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters", Nat Med, 15, pp.930~939 (2009)
88. Li C, "Interferon-α-producing plasmacytoid dendritic cells drive the loss of adipose tissue regulatory T cells during obesity", Cell Metab, 33, pp.1610~1623 (2021)
89. Medrikova D, "Brown adipose tissue harbors a distinct sub-population of regulatory T cells", PLoS One, 10, pp.e0118534~ (2015)
90. Kälin S, "A Stat6", Pten axis links regulatory T cells with adipose tissue function, 2017, pp.26, 475~492
91. Fang W, "Regulatory T cells promote adipocyte beiging in subcutaneous adipose tissue", FASEB J, 34, pp.9755~9770 (2020)

관련 논문AI추천